A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Year to date metric has recorded a gain of 43.78%.However, over the last six months, we can see a stronger performance of -9.68%. Over the last 30 days, the price of EFTR has fallen by 9.79%. And in the last five days, it has surged by 8.99%.
eFFECTOR Therapeutics Inc (EFTR) currently has a stock price of $0.61. The stock saw a sharp increase in the last trading session, hitting a high of $0.6101 after opening at $0.61. The lowest recorded price for the day was $0.58 before it closed at $0.59.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
eFFECTOR Therapeutics Inc’s stock has had a calm market performance. The 1-year high for the company’s stock was $1.48 on 06/06/23, and the lowest price during the same period was recorded at $0.34 on 03/30/23.
52-week price history of EFTR Stock
A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. eFFECTOR Therapeutics Inc’s current trading price is -58.46% away from its 52-week high, while its distance from the 52-week low is 82.00%. The stock’s price range over this timeframe has been between $0.34 and $1.48. The shares of the Healthcare sector company recorded a trading volume of approximately 3.21 million for the day, which was comparatively higher than the average daily volume of 0.52 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
eFFECTOR Therapeutics Inc (EFTR) has experienced a quarterly decline of -13.41% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 39.73M and boasts a workforce of 15 employees.
Expert Opinions: Analysts’ Ratings for eFFECTOR Therapeutics Inc
As of right now, 4 analysts are rating eFFECTOR Therapeutics Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.6475, with a change in price of -0.2172. Similarly, eFFECTOR Therapeutics Inc recorded 568,306 in trading volume during the last 100 days, posting a change of -26.16%.
EFTR Stock Stochastic Average
eFFECTOR Therapeutics Inc’s raw stochastic average for the past 50 days is currently at 71.12%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 79.23%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 70.00% and 67.88%, respectively.
